Variable | Total assessed, N | Success, n (%) | Nonsuccess, n (%) | RR, (95% CI) | aRR, (95% CI) |
---|---|---|---|---|---|
2010–2011 | 11,869 | 10,388 (87.5) | 1,481 (12.5) | 1 | 1 |
2014–2015 | 8,301 | 6,519 (78.5) | 1,782 (21.5) | 0.90 (0.89–0.91)* | 0.91 (0.90–0.92)* |
60–69 | 10,109 | 8,943 (88.5) | 1,166 (11.5) | 1 | 1 |
70–79 | 6,898 | 5,719 (82.9) | 1,179 (17.1) | 0.94 (0.93–0.95)* | 0.94 (0.93–0.95)* |
80–89 | 2,913 | 2,110 (72.4) | 803 (27.6) | 0.82 (0.80–0.84)* | 0.83 (0.81–0.85)* |
90 | 250 | 135 (54.0) | 115 (46.0) | 0.61 (0.54–0.68)* | 0.61 (0.55–0.68)* |
Male | 13,505 | 11,215 (83.0) | 2,290 (17.0) | 1 | 1 |
Female | 6,636 | 5,673 (85.5) | 963 (14.5) | 1.03 (1.02–1.04)* | 1.03 (1.02–1.04)* |
Variable | Total assessed, N | Death, n (%) | Not death, n (%) | RR (0.95% CI) | aRR (0.95% CI) |
---|---|---|---|---|---|
2010–2011 | 11,869 | 976 (8.2) | 10,893 (91.8) | 1 | 1 |
2014–2015 | 8,301 | 1,325 (16.0) | 6,976 (84.0) | 1.94 (1.80–2.10)* | 2.01 (1.86–2.17)* |
60–69 | 10,109 | 677 (6.7) | 9,432 (93.3) | 1 | 1 |
70–79 | 6,898 | 865 (12.5) | 6,033 (87.5) | 1.87 (1.70–2.06)* | 1.95 (1.78–2.15)* |
80–89 | 2,913 | 658 (22.6) | 2,255 (77.4) | 3.37 (3.05–3.72)* | 3.58 (3.24–3.94)* |
≥90 | 250 | 101 (40.4) | 149 (59.6) | 6.03 (5.10–7.13)* | 6.19 (5.26–7.28)* |
Male | 13,505 | 1,612 (11.9) | 11,893 (88.1) | 1 | 1 |
Female | 6,636 | 681 (10.3) | 5,955 (89.7) | 0.86 (0.79–0.94)* | 0.78 (0.72–0.85)* |